Connect to other sites within the UBM Medica Network
Genomic Marker Predicted Anti–PD-1 Response in Colorectal Cancer
Colorectal tumors that lacked the ability to repair DNA were found to be highly responsive to checkpoint blockade with the anti–PD-1 drug pembrolizumab.
Immunotherapy for Genitourinary Cancers Still in Infancy
Ahead of the 2015 ASCO Annual Meeting, we are discussing the role of immunotherapy in genitourinary cancers with Susan F. Slovin, MD, PhD.
ASCO Obesity Initiative: How Does Obesity Affect Cancer Outcomes?
Jennifer Ligibel, MD, discusses the link between obesity and cancer as part of ASCO's obesity initiative ahead of this year's ASCO Annual Meeting.
Aflatoxin Linked to Risk of Gallbladder Cancer
Aflatoxin, a naturally occurring toxin produced by certain types of molds, has been found to be associated with an increased risk of gallbladder cancer.
Results From the Multiple Myeloma Trials
We discuss some of the anticipated multiple myeloma trials with Sagar Lonial, MD, ahead of the 2015 American Society of Clinical Oncology Annual Meeting.
Views on Alternative Medicines Predict Use in Cancer Patients
A survey showed that cancer patients' attitudes about alternative medicines explained their use more so than demographics and clinical characteristics.
Vast Majority of Advanced Prostate Tumors Have Actionable Mutations
A large majority of prostate tumors sequenced as part of a comprehensive precision medicine study have mutations that can be targeted with available therapies.
Resection, Cs131, SBRT All Strong Options for Early-Stage Lung Cancer
A treatment analysis for early NSCLC found that wedge resection, along with Cs131 brachytherapy, and stereotactic body radiation therapy are all strong options.
Evidence Moves OTC Prevention of mCRC Closer to Reality
Ahead of the 2015 ASCO Annual Meeting, we are discussing over-the-counter therapies for patients with metastatic colorectal cancer with Andrew T. Chan, MD, MPH.
Criteria ID’d for Diagnosing Skin Cancer With Reflectance Confocal Microscopy
Researchers have identified several key diagnostic criteria for the diagnosis of melanoma and basal cell carcinoma with reflectance confocal microscopy.
By clicking Accept, you agree to become a member of the UBM Medica Community.